EP2048236 - Bibliographic data

Gene expression technique

Last update 16/07/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

NOVOZYMES BIOPHARMA DK A/S

Krogshoejvej 36
2880 Bagsvaerd
Danemark
(72) Inventors

Sleep, Darrell Novozymes Biopharma UK Limited

Castle Court 59 Castle Boulevard
Nottingham Nottinghamshire NG7 1FD
Royaume-Uni

Shuttleworth, Gillian Novozymes Biopharma UK Limited

Castle Court 59 Castle Boulevard
Nottingham Nottinghamshire NG7 1FD
Royaume-Uni

Finnis, Christopher John Arthur Novozymes Biopharma UK Limited

Castle Court 59 Castle Boulevard
Nottingham, Nottinghamshire NG7 1FD
Royaume-Uni
(74) Agent

Mail recipient

WILLIAMS, RACHEL CLARE ET AL

Novozymes Biopharma UK Limited Castle Court 59 Castle Boulevard
Nottingham NG7 1FD
Royaume-Uni

(21) Request number EP08169442.4
(22) Request date 23/12/2004

(11) Publication number EP2048236
Publication date 20/03/2013

(54) Title of the invention Gene expression technique
(51) International classification C12N 15/80C12N 15/67C12N 5/10
International classification (before reform) None

Claimed priority

(31) Number: 0329681
(32) Date: 23/12/2003
(33) Country: GB

Initial application None
Divisional application None

Expected annuity Annuity: 10 - Amount: 135 € - Due date 02/01/2014
Surtax: 10 - Amount: 27 € - Due date 03/07/2014
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/1, of 31/03/2013

History

Publication de la délivrance du brevet européen - Legal date 20/03/2013


Entrée en période de grâce du brevet d'invention - Legal date 03/01/2014


Déchéance du brevet d'invention après période de grâce - Legal date 02/01/2014